News & Updates

Show Multimedia Only

Izokibep maintains PsA efficacy at 52 weeks

04 Aug 2026 by

The novel small-protein IL-17 inhibitor izokibep demonstrates durable efficacy and a favourable safety profile over 52 weeks in patients with active psoriatic arthritis (PsA), with sustained improvements in joint, skin, and quality-of-life outcomes in a phase IIB/III study.

Izokibep maintains PsA efficacy at 52 weeks

04 Aug 2026

Blood p-Tau217 levels prognostic of cognitive decline risk

04 Aug 2026 by

A large, multicohort study of cognitively unimpaired older adults has found that higher plasma p-tau217 levels are consistently associated with greater risk of progression to cognitive impairment and faster rates of cognitive decline, providing time-specific absolute risk estimates and supporting the potential of p-tau217 for prognostic model development.

Blood p-Tau217 levels prognostic of cognitive decline risk

04 Aug 2026

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

03 Aug 2026

In the treatment of patients with anti–PD-(L)1–resistant advanced melanoma, response with ceralasertib plus durvalumab is low, according to the phase II MONETTE study.

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

03 Aug 2026

Study warns of adulterated complementary health products

03 Aug 2026 by

Some complementary health products (CHPs), such as health supplements, contain undeclared substances that pose significant health risks, according to a study.

Study warns of adulterated complementary health products

03 Aug 2026

Low FT levels linked to frailty in men with advanced CLD

03 Aug 2026

Low levels of free testosterone (FT) appear to contribute to frailty in male patients with advanced chronic liver disease (CLD), according to a study.

Low FT levels linked to frailty in men with advanced CLD

03 Aug 2026

Sexual desire trajectories vary during medically assisted reproduction

03 Aug 2026 by

Trajectories of sexual desire tend to differ in couples with medical infertility undergoing medically assisted reproduction (MAR), and some types are better predicted by education and relationship satisfaction, suggests a recent study.

Sexual desire trajectories vary during medically assisted reproduction

03 Aug 2026

IBD tied to higher risks of MACE, recurrent MI, all-cause mortality

03 Aug 2026

Patients with inflammatory bowel disease (IBD) are at increased risks of major adverse cardiovascular events (MACE), all-cause mortality, recurrent myocardial infarction (MI), blood transfusions, and major bleeding relative to those without IBD, a study has found.

IBD tied to higher risks of MACE, recurrent MI, all-cause mortality

03 Aug 2026

Elevated p-tau217 levels may help identify dementia risk early

03 Aug 2026 by

A pooled analysis presented at AAIC^® 2026 demonstrated a consistent association between higher levels of plasma phosphorylated tau 217 (p-tau217) and an increased risk of clinical progression and accelerated cognitive decline in a large cohort of older adults without cognitive impairment.

Elevated p-tau217 levels may help identify dementia risk early

03 Aug 2026

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation

03 Aug 2026

High-dose vitamin D shows promise in the treatment of toxic erythema of chemotherapy (TEC) and acute radiation dermatitis (ARD), according to a retrospective study.

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation

03 Aug 2026

AI-OCT for DME secondary screening cuts false-positive referrals by 45 percent

03 Aug 2026 by

An AI-based optical coherence tomography (AI-OCT) system for add-on secondary screening of diabetic macula oedema (DME) reduces false-positive DME referrals by 45 percent vs standard screening by fundus photography alone, a randomized controlled trial (RCT) in Hong Kong has shown.

AI-OCT for DME secondary screening cuts false-positive referrals by 45 percent

03 Aug 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Izokibep maintains PsA efficacy at 52 weeks

Izokibep maintains PsA efficacy at 52 weeks

Blood p-Tau217 levels prognostic of cognitive decline risk

Blood p-Tau217 levels prognostic of cognitive decline risk

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

Study warns of adulterated complementary health products

Study warns of adulterated complementary health products

Low FT levels linked to frailty in men with advanced CLD

Low FT levels linked to frailty in men with advanced CLD

Sexual desire trajectories vary during medically assisted reproduction

Sexual desire trajectories vary during medically assisted reproduction

IBD tied to higher risks of MACE, recurrent MI, all-cause mortality

IBD tied to higher risks of MACE, recurrent MI, all-cause mortality

Elevated p-tau217 levels may help identify dementia risk early

Elevated p-tau217 levels may help identify dementia risk early

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation

AI-OCT for DME secondary screening cuts false-positive referrals by 45 percent

AI-OCT for DME secondary screening cuts false-positive referrals by 45 percent